MT Group


MT Group is a biospecimen contract research organization that sources, curates, and supplies annotated human biospecimens to support translational research, drug development, and diagnostic programs. The company provides custom collections, biobank repository services, disease-focused programs (e.g., autoimmune, NASH, immuno‑oncology), and clinical annotation services to pharmaceutical, biotechnology, diagnostic and academic customers.

Industries

biotechnology
health-care
health-diagnostics
pharmaceutical

Nr. of Employees

small (1-50)

MT Group

Los Angeles, California, United States, North America


Services

Design and fulfillment of bespoke specimen collections with defined inclusion criteria, timepoints and comprehensive clinical annotation.

Fulfillment of biobank requests including matched FFPE, frozen tissue and blood components for translational and assay development studies.

End-to-end biospecimen acquisition and coordination services, including site management, sample processing, annotation and logistics.

Programmatic collections and cohorts curated for specific disease areas with linked clinical data and longitudinal follow-up.

Partnerships with community and academic centers to expand collection capacity and enable targeted cohort access.

Expertise Areas

  • Biospecimen procurement and supply
  • Biobanking and repository management
  • Clinical annotation and metadata management
  • Immuno-oncology biospecimens
  • Show More (6)

Key Technologies

  • Formalin-fixed paraffin-embedded (FFPE) tissue handling
  • Fresh frozen tissue procurement
  • Double-spun plasma processing
  • Buffy coat isolation
  • Show More (4)

News & Updates

Blog post discussing the impact of pre-analytical variables on assay performance and the importance of consistent specimen handling and metadata.

Blog post outlining critical factors that influence sample quality, clinical data completeness and study success in biospecimen collection.

Overview of how high-quality clinical biospecimens support research across academic and commercial projects.

Post summarizing network growth, newly supported disease areas and example studies and cohorts expanded in 2022.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.